----------------------- Advertisement --------------------------

New Drug For Treating Schizophrenia Approved


New Drug For Treating Schizophrenia Approved

Drug firm Lupin today said it has received US health regulator's approval to market generic version of Seroquel XR tablets, used in the treatment of schizophrenia, in the American market.

The company has received final approval for its Quetiapine Fumarate extended-release tablets in different strengths from the United States Food and Drug Administration (FDA), Lupin Ltd said in a statement.

The Mumbai-based company's product is generic equivalent of AstraZeneca Pharmaceuticals LP's Seroquel XR tablets which are indicated for the treatment of schizophrenia.

As per IMS MAT March sales data, Seroquel XR extended-release tablets had US sales of USD 1.27 billion. Lupin shares today ended 0.61 per cent up at Rs 1,304.90 on the BSE.

Schizophrenia is a complex mental illness in which a person loses the ability to think, feel or behave normally. The patient seems to “live in a distorted world”, and is usually unaware of his illness. The disorder is more commonly seen in men than women. Men tend to show the symptoms in their late teens and early twenties whereas in women, the illness is manifested later during their thirties. Nearly 6-7 million Indians suffer from this disorder, which is now believed to be a brain disorder rather than a purely psychological illness.

How is it treated Treatment approach to schizophrenia is long term and multi-pronged. It comprises not only medical intervention, but also psychological, behavioural and social rehabilitation.

(With inputs from PTI)

Friday, 19 May 2017
----------------------- Advertisement4 --------------------------
Latest Photos
-------------------------------- Advertisement -----------------------------------